[go: up one dir, main page]

BRPI0516408A - derivados de estilbeno e seu uso para ligação e formação de imagem de placas de amilóide - Google Patents

derivados de estilbeno e seu uso para ligação e formação de imagem de placas de amilóide

Info

Publication number
BRPI0516408A
BRPI0516408A BRPI0516408-7A BRPI0516408A BRPI0516408A BR PI0516408 A BRPI0516408 A BR PI0516408A BR PI0516408 A BRPI0516408 A BR PI0516408A BR PI0516408 A BRPI0516408 A BR PI0516408A
Authority
BR
Brazil
Prior art keywords
imaging
binding
amyloid
amyloid plaques
stilbene derivatives
Prior art date
Application number
BRPI0516408-7A
Other languages
English (en)
Inventor
Hank F Kung
Mei-Ping Kung
Zhi-Ping Zhuang
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of BRPI0516408A publication Critical patent/BRPI0516408A/pt
Publication of BRPI0516408B1 publication Critical patent/BRPI0516408B1/pt
Publication of BRPI0516408B8 publication Critical patent/BRPI0516408B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/02—Monocyclic hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A61K31/115—Formaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

DERIVADOS DE ESTILBENO E SEU USO PARA LIGAçãO E FORMAçãO DE IMAGEM DE PLACAS DE AMILóIDE. A presente invenção refere-se a um método de formação de imagem de depósitos de amilóide e aos compostos rotulados, e métodos de preparação de compostos rotulados úteis em formação de imagem de depósitos de amilóide. Esta invenção também refere-se aos compostos, e métodos de preparação de compostos para inibição da agregação de proteínas amilóides para formar depósitos amilóides, e um método de liberação de um agente terapêutico aos depósitos de amilóide.
BRPI0516408A 2004-12-17 2005-12-19 derivados de estilbeno e seu uso para ligação e formação de imagem de placas de amilóide BRPI0516408B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63669604P 2004-12-17 2004-12-17
US60/636,696 2004-12-17
US68639505P 2005-06-02 2005-06-02
US60/686,395 2005-06-02
PCT/US2005/045682 WO2006066104A2 (en) 2004-12-17 2005-12-19 Stilbene derivatives and their use for binding and imaging amyloid plaques

Publications (3)

Publication Number Publication Date
BRPI0516408A true BRPI0516408A (pt) 2008-09-02
BRPI0516408B1 BRPI0516408B1 (pt) 2021-03-23
BRPI0516408B8 BRPI0516408B8 (pt) 2021-05-25

Family

ID=36588603

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516408A BRPI0516408B8 (pt) 2004-12-17 2005-12-19 derivados de estilbeno e seu uso para ligação e formação de imagem de placas de amilóide

Country Status (25)

Country Link
US (2) US7807135B2 (pt)
EP (3) EP1841465A4 (pt)
JP (1) JP5128956B2 (pt)
KR (1) KR101321619B1 (pt)
AU (1) AU2005316421B2 (pt)
BE (1) BE2015C015I2 (pt)
BR (1) BRPI0516408B8 (pt)
CA (1) CA2591534C (pt)
DK (1) DK2213652T3 (pt)
EA (1) EA012334B1 (pt)
ES (1) ES2526655T3 (pt)
FR (1) FR15C0012I2 (pt)
HU (1) HUS1500014I1 (pt)
IL (2) IL183946A (pt)
LT (1) LTC2213652I2 (pt)
LU (1) LU92647I2 (pt)
MX (1) MX2007007380A (pt)
NL (1) NL300719I1 (pt)
NO (1) NO339195B1 (pt)
NZ (1) NZ555942A (pt)
PL (1) PL2213652T3 (pt)
PT (1) PT2213652E (pt)
SG (1) SG194363A1 (pt)
SI (1) SI2213652T1 (pt)
WO (1) WO2006066104A2 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1432453T3 (da) * 2001-08-27 2013-11-18 Univ Pennsylvania Stilbenderivater og anvendelse heraf til binding og billeddannelse af amyloid-plaques
US7858072B2 (en) * 2004-12-17 2010-12-28 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
EP1841465A4 (en) * 2004-12-17 2009-04-01 Univ Pennsylvania STYLENE DERIVATIVES AND THEIR USE OF THE BINDING AND IMAGE DISPLAY OF AMYLOID PLAQUE
CA2617319A1 (en) * 2005-06-24 2007-01-04 The Trustees Of The University Of Pennsylvania Radiolabeled-pegylation of ligands for use as imaging agents
EP2363392B1 (en) 2006-03-30 2017-05-03 The Trustees Of The University Of Pennsylvania Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
US20080253967A1 (en) * 2007-04-13 2008-10-16 Kung Hank F Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques
WO2009001046A2 (en) * 2007-06-22 2008-12-31 The University Court Of The University Of Aberdeen [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use
EP2172444A4 (en) * 2007-07-04 2010-12-22 Univ Tohoku PET PROBE WITH FLUORO-SUBSTITUTED ALKOXY GROUP AND HYDROXYGRUPPE
US8779002B2 (en) * 2007-10-15 2014-07-15 Salk Institute For Biological Studies Methods for treating a variety of diseases and conditions, and compounds useful therefor
US8932557B2 (en) 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
PL2247558T5 (pl) * 2008-02-14 2024-10-14 Eli Lilly And Company Nowe środki obrazujące do wykrywania czynnościowych zaburzeń neurologicznych
US20100331676A1 (en) * 2008-02-27 2010-12-30 Avid Radiopharmaceuticals, Inc. Gamma probe detection of amyloid plaque using radiolabeled a-beta binding compounds
US8557222B2 (en) * 2008-04-04 2013-10-15 Avid Radiopharmaceuticals, Inc. Radiopharmaceutical imaging of neurodegenerative diseases
US20100145194A1 (en) * 2008-11-13 2010-06-10 Avid Radiopharmaceuticals, Inc. Histogram-based analysis method for the detection and diagnosis of neurodegenerative diseases
EP2379757A2 (en) 2008-12-22 2011-10-26 Bayer Pharma Aktiengesellschaft A method for the synthesis of a radionuclide-labeled compound
SG172439A1 (en) * 2008-12-31 2011-07-28 Avid Radiopharmaceuticals Inc Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
CU23844B1 (es) 2009-04-17 2012-10-15 Ct De Neurociencias De Cuba Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer
CA2767475A1 (en) 2009-07-10 2011-01-13 Bayer Pharma Aktiengesellschaft Usage of low to medium-pressure liquid chromatography for the purification of radiotracers
EA022447B1 (ru) * 2009-12-23 2016-01-29 Пирамаль Имэджинг Са Композиции, приемлемые для рет-визуализации при помощи гидрофобных рет-агентов
WO2011151283A1 (en) * 2010-06-04 2011-12-08 Bayer Pharma Aktiengesellschaft Method for production of f-18 labeled amyloid beta ligands
CN103328012A (zh) 2010-06-04 2013-09-25 皮拉马影像股份公司 生产F-18标记的β-淀粉样蛋白配体的方法
US20130217920A1 (en) 2010-06-04 2013-08-22 Piramal Imaging Sa Method for production of f-18 labeled amyloid beta ligands
TWI504414B (zh) * 2010-06-04 2015-10-21 Bayer Schering Pharma Ag 生產Ｆ－１８標記之Ａβ配位體之方法
US9259495B2 (en) * 2010-10-12 2016-02-16 Mayo Foundation For Medical Education And Research Imaging of meningiomas using phenylbenzothiazole, stilbene, or biphenylalkyne derivatives
EP3345545B1 (en) 2011-04-21 2021-10-20 The Regents of The University of California Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
ES2683818T3 (es) * 2011-06-21 2018-09-28 Piramal Imaging Sa Formulaciones de estilbeno fluorado aceptables para la formación de imágenes mediante PET
KR101291037B1 (ko) * 2011-10-12 2013-08-01 사회복지법인 삼성생명공익재단 레스베라트롤 유도체와 스티릴-오각형 방향족 화합물 및 이들의 베타-아밀로이드 플라그에 대한 결합제 및 진단영상제의 용도
RU2477726C1 (ru) * 2011-10-18 2013-03-20 Общество С Ограниченной Ответственностью "Ньювак" (Ооо "Ньювак") Замещенные феноксиуксусные кислоты, их эфиры и амиды, включающие 2,6-диоксо-2,3,6,7-тетрагидро-1н-пурин-8-иловый фрагмент, - антагонисты аденозинового a2a рецептора и их применение
MX2014004274A (es) 2011-10-19 2014-07-09 Piramal Imaging Sa METODO MEJORADO PARA LA PRODUCCION DE LIGANDOS Aß MARCADOS CON F-18.
WO2013173004A2 (en) 2012-04-10 2013-11-21 Lantheus Medical Imaging, Inc. Radiopharmaceutical synthesis methods
US9180212B2 (en) * 2012-05-22 2015-11-10 The Regents Of The University Of California β-amyloid plaque imaging agents
CU20130027A7 (es) 2013-02-28 2014-10-30 Ct De Neurociencias De Cuba Chaperoninas químicas como nuevos moduladores moleculares de la beta agregación proteica presente en las enfermedades conformacionales
JP6041751B2 (ja) * 2013-05-07 2016-12-14 日本メジフィジックス株式会社 スチリルピリジン誘導体化合物
JP2014218454A (ja) * 2013-05-07 2014-11-20 日本メジフィジックス株式会社 スチリルピリジン誘導体化合物
KR101891404B1 (ko) * 2015-12-18 2018-08-24 주식회사 엘지화학 변성 단량체, 이를 포함하는 변성 중합체 및 이들의 제조방법
US10675365B2 (en) 2016-09-29 2020-06-09 Korea Atomic Energy Research Institute Curcumin derivative, method for producing same, and photo-acoustic imaging agent comprising same for detecting beta-amyloid plaque
JOP20190077A1 (ar) 2016-10-10 2019-04-09 Array Biopharma Inc مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500507A (en) * 1981-10-30 1985-02-19 Wong Dennis W Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
JPS60247244A (ja) 1984-05-22 1985-12-06 Mitsubishi Paper Mills Ltd 電子写真感光体
DD234666A1 (de) 1984-11-01 1986-04-09 Univ Leipzig Verfahren zur herstellung von einfachen und substituierten 4-dimethylamino-alpha-halogenstilbenen
DD231432A1 (de) * 1984-11-01 1985-12-24 Univ Leipzig Material zur silberfreien bildaufzeichnung
JPH06329566A (ja) 1993-05-21 1994-11-29 Asahi Glass Co Ltd ジフルオロスチルベン誘導体化合物およびそれを含有する液晶組成物
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5601801A (en) 1994-08-02 1997-02-11 Merck Frosst Canada, Inc. Radiolabelled angiotensin converting enzyme inhibitors
US5521213A (en) * 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
JP4022951B2 (ja) 1997-08-06 2007-12-19 大日本インキ化学工業株式会社 ジフルオロスチルベン誘導体の製造方法
WO2001084937A1 (en) * 2000-05-08 2001-11-15 Novozymes A/S Oxidoreductase mediated antimicrobial activity
DK1432453T3 (da) * 2001-08-27 2013-11-18 Univ Pennsylvania Stilbenderivater og anvendelse heraf til binding og billeddannelse af amyloid-plaques
KR100789847B1 (ko) * 2004-12-15 2007-12-28 (주)퓨쳐켐 알코올 용매하에서 유기플루오로 화합물의 제조방법
US7858072B2 (en) 2004-12-17 2010-12-28 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
EP1841465A4 (en) * 2004-12-17 2009-04-01 Univ Pennsylvania STYLENE DERIVATIVES AND THEIR USE OF THE BINDING AND IMAGE DISPLAY OF AMYLOID PLAQUE
CA2617319A1 (en) * 2005-06-24 2007-01-04 The Trustees Of The University Of Pennsylvania Radiolabeled-pegylation of ligands for use as imaging agents

Also Published As

Publication number Publication date
EP1841465A4 (en) 2009-04-01
AU2005316421A1 (en) 2006-06-22
EA200701299A1 (ru) 2007-12-28
LU92647I2 (fr) 2015-11-03
JP2008524243A (ja) 2008-07-10
SG194363A1 (en) 2013-11-29
CA2591534C (en) 2013-08-06
LTC2213652I2 (lt) 2016-12-27
NO339195B1 (no) 2016-11-14
SI2213652T1 (sl) 2015-03-31
AU2005316421B2 (en) 2012-04-05
NL300719I2 (pt) 2015-12-29
NZ555942A (en) 2011-01-28
US8465726B2 (en) 2013-06-18
PT2213652E (pt) 2015-01-02
US20060269473A1 (en) 2006-11-30
EA012334B1 (ru) 2009-08-28
EP2213652A1 (en) 2010-08-04
EP1841465A2 (en) 2007-10-10
KR101321619B1 (ko) 2013-10-30
BRPI0516408B1 (pt) 2021-03-23
EP2213652B1 (en) 2014-10-22
WO2006066104A3 (en) 2006-08-03
KR20070093427A (ko) 2007-09-18
NL300719I1 (pt) 2015-12-29
EP1838298A4 (en) 2009-03-04
BRPI0516408B8 (pt) 2021-05-25
EP1838298A2 (en) 2007-10-03
ES2526655T3 (es) 2015-01-14
BE2015C015I2 (pt) 2025-04-29
IL206091A (en) 2013-08-29
WO2006066104A2 (en) 2006-06-22
FR15C0012I1 (pt) 2015-03-20
US7807135B2 (en) 2010-10-05
US20100266500A1 (en) 2010-10-21
DK2213652T3 (en) 2015-01-26
IL183946A0 (en) 2007-10-31
HUS1500014I1 (hu) 2016-11-28
IL183946A (en) 2011-08-31
FR15C0012I2 (fr) 2015-11-20
PL2213652T3 (pl) 2015-04-30
MX2007007380A (es) 2007-10-11
CA2591534A1 (en) 2006-06-22
JP5128956B2 (ja) 2013-01-23
NO20073650L (no) 2007-09-14

Similar Documents

Publication Publication Date Title
BRPI0516408A (pt) derivados de estilbeno e seu uso para ligação e formação de imagem de placas de amilóide
EA200870389A1 (ru) Стирилпиридиновые производные и их применение для связывания и визуализации амилоидных бляшек
CY2017013I2 (el) ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ
CR10842A (es) Derivados de acetileno y su uso para la union a placas amiloides y su diagnostico por imagenes
BRPI0507684A (pt) agentes de contraste para formação de imagem de perfusão miocárdica
BRPI0811816A2 (pt) "forma de dosagem de picoplatina estabilizada, método para preparar uma forma de dosagem de picoplatina estabilizada, composições, kit, pluralidade de kits, método para tratamento de câncer e uso de uma quantidade eficaz da forma de dosagem"
BRPI1012993A2 (pt) "uso de um anticorpo anti-tau ps422 para o tratamento de doenças do cérebro"
BRPI0610359B8 (pt) compostos de diaril-hidantoína, suas composições farmacêuticas e sais farmaceuticamente aceitáveis
BRPI0813237A2 (pt) Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
BRPI0810208A2 (pt) Combinação de terapias compreendendo inibidores p13k-alpha à base de quinoxalina para uso no tratamento do câncer.
HRP20170250T1 (hr) Dvofazni pripravak lipidnih vezikula i postupak za liječenje cervikalne displazije intravaginalnom isporukom
WO2006078384A3 (en) Stilbene derivatives and their use
EA200801875A1 (ru) Антагонист cd 80
CL2007002525A1 (es) Forma cristalina qalfa de maleato de (r)-5-[2-(5,6-dietil-indan-2-il-amino)-1-hidroxi-etil]-8-hidroxi-1h-quinolin-2-ona; procedimiento de preparacion; composicion farmaceutica que lo comprende; y uso para el tratamiento de una enfermedad inflamatoria
GT200900087A (es) Quelatos metalicos con radical peg perflurado metodo para su preparacion y su uso.
BRPI0906395A2 (pt) composição farmacêutica, uso de pelo menos um composto ou um sal farmacologicamente aceitável do mesmo, kit, e, método para tratar ou melhorar as doenças cardíacas
CR9206A (es) Derivados de estilbeno y su uso para estudios de union y por imagenes de placas amiloides
ES2446494B1 (es) Aplicación terapéutica de necrostatina-1 en esteatohepatitis
WO2010135493A3 (en) Alzheimer's disease imaging agents
ECSP099393A (es) Derivados de acetileno y su uso para la unión a placas amiloides y su diagnóstico por imágenes
CL2008000663A1 (es) Forma cristalina de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il)triazol-4-il)benzonitrilo; metodo de preparacion; composicion farmaceutica; kit farmaceutico; y uso para tratar sindrome de ovario poliquistico, cancer, entre otras enfermedades.
BRPI0514136A (pt) polimorfo cristalino de monoidrato de hidrocloreto de pipindoxifeno, composição, método para preparar a forma ii polimórfica de monoidrato de hidrocloreto de pipindoxifeno, forma ii polimórfica de monoidrato de hidrocloreto de pipindoxifeno, método de preparação do polimorfo, métodos de tratamento de um mamìfero tendo uma doença ou sìndrome, ou um distúrbio, de redução de colesterol, de inibição de perda óssea, de tratamento de cáncer de mama em um mamìfero, e de tratamento de uma mulher na pós-menopausa, e, uso de um polimorfo
TH95066B (th) สูตรการสร้างภูมิคุ้มกันแบบโมโนโคลนของมนุษย์สำหรับการต่อต้าน igf-1r
UY32216A (es) Formas de sales sulfato de la tianeptina y métodos para su preparación y uso

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/12/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF